Mathematical model predicts response to chemotherapy in advanced non-resectable non-small cell lung cancer patients treated with platinum-based doublet.
We developed a computational platform including machine learning and a mechanistic mathematical model to find the optimal protocol for administration of platinum-doublet chemotherapy in a palliative setting. The platform has been applied to advanced metastatic non-small cell lung cancer (NSCLC). The...
Main Authors: | Emilia Kozłowska, Rafał Suwiński, Monika Giglok, Andrzej Świerniak, Marek Kimmel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-10-01
|
Series: | PLoS Computational Biology |
Online Access: | https://doi.org/10.1371/journal.pcbi.1008234 |
Similar Items
-
Polymorphisms in <i>EGFR</i> Gene Predict Clinical Outcome in Unresectable Non-Small Cell Lung Cancer Treated with Radiotherapy and Platinum-Based Chemoradiotherapy
by: Dorota Butkiewicz, et al.
Published: (2021-05-01) -
Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet Chemotherapy
by: Desirée Hao, et al.
Published: (2020-07-01) -
Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy
by: Jyoti Bhagatram Sharma, et al.
Published: (2021-02-01) -
Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy
by: Mio Tadashi, et al.
Published: (2010-11-01) -
Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer
by: Rafał Suwinski, et al.
Published: (2019-05-01)